• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自身免疫性甲状腺疾病(AITD)中具有碘摄取抑制活性的抗钠/碘同向转运体(NIS)抗体的罕见性。

Rarity of anti- Na+/I- symporter (NIS) antibody with iodide uptake inhibiting activity in autoimmune thyroid diseases (AITD).

作者信息

Chin H S, Chin D K, Morgenthaler N G, Vassart G, Costagliola S

机构信息

IRIBHN, Faculty of Medicine, Free University of Brussels, Belgium.

出版信息

J Clin Endocrinol Metab. 2000 Oct;85(10):3937-40. doi: 10.1210/jcem.85.10.6884.

DOI:10.1210/jcem.85.10.6884
PMID:11061560
Abstract

The search for antibody against the Na+/I- symporter (NIS) has seen conflicting results over the years. Prior to cloning of NIS, Raspe et al found iodide uptake inhibiting sera were rare in autoimmune thyroid diseases (AITD) while post-cloning, others reported the presence of antibody in 12-15% of Hashimoto's thyroiditis (HT) and 30-84% of Graves' disease (GD). To evaluate the role of NIS as a potential antigen in AITD, a stable COS 7 cell line expressing high level of functional hNIS was established which allowed the screening of large number of sera for iodide uptake inhibiting activity in a 96-well plate format. Five hundred and fourteen serum samples taken from normal subjects and patients with AITD, non-autoimmune thyroid diseases, and non-thyroid autoimmune diseases were assayed for presence of iodide uptake inhibiting activity. Under the influence of these sera, iodide uptake showed a normal frequency distribution and diminution of uptake 2 SDs below the mean of controls was observed with 14 sera. Among these, 7 that were available for further study were re-evaluated after dialysis and/or Ig G extraction. All 7 sera lost their iodide uptake inhibiting activity, indicating that the effects were not antibody mediated and unknown serum factors had been responsible. In conclusion, contrary to previous results, the present study indicates that antibodies capable of modulating NIS activity are rare in AITD.

摘要

多年来,针对钠/碘同向转运体(NIS)抗体的研究结果一直存在矛盾。在NIS克隆之前,拉斯佩等人发现自身免疫性甲状腺疾病(AITD)中抑制碘摄取的血清很少见,而在克隆之后,其他人报告在12%至15%的桥本甲状腺炎(HT)和30%至84%的格雷夫斯病(GD)中存在抗体。为了评估NIS作为AITD潜在抗原的作用,建立了一个稳定表达高水平功能性人NIS的COS 7细胞系,这使得能够以96孔板形式筛选大量血清的碘摄取抑制活性。对从正常受试者以及患有AITD、非自身免疫性甲状腺疾病和非甲状腺自身免疫性疾病的患者采集的514份血清样本进行了碘摄取抑制活性检测。在这些血清的影响下,碘摄取呈现正常的频率分布,14份血清观察到摄取量减少至低于对照组平均值2个标准差。其中,可用于进一步研究的7份血清在透析和/或提取IgG后重新进行了评估。所有7份血清均失去了碘摄取抑制活性,这表明这些影响不是由抗体介导的,而是由未知的血清因子导致的。总之,与之前的结果相反,本研究表明在AITD中能够调节NIS活性的抗体很少见。

相似文献

1
Rarity of anti- Na+/I- symporter (NIS) antibody with iodide uptake inhibiting activity in autoimmune thyroid diseases (AITD).自身免疫性甲状腺疾病(AITD)中具有碘摄取抑制活性的抗钠/碘同向转运体(NIS)抗体的罕见性。
J Clin Endocrinol Metab. 2000 Oct;85(10):3937-40. doi: 10.1210/jcem.85.10.6884.
2
Detection of binding and blocking autoantibodies to the human sodium-iodide symporter in patients with autoimmune thyroid disease.自身免疫性甲状腺疾病患者中针对人钠碘同向转运体的结合和阻断自身抗体的检测
J Clin Endocrinol Metab. 2000 May;85(5):2020-7. doi: 10.1210/jcem.85.5.6526.
3
Low frequency of autoantibodies to the human Na(+)/I(-) symporter in patients with autoimmune thyroid disease.自身免疫性甲状腺疾病患者中针对人钠/碘同向转运体自身抗体的低频率。
J Clin Endocrinol Metab. 2000 Dec;85(12):4630-4. doi: 10.1210/jcem.85.12.7050.
4
Autoantibodies from patients with autoimmune thyroid disease do not interfere with the activity of the human iodide symporter gene stably transfected in CHO cells.自身免疫性甲状腺疾病患者的自身抗体不会干扰稳定转染于CHO细胞中的人碘转运体基因的活性。
Eur J Endocrinol. 2001 Jun;144(6):611-8. doi: 10.1530/eje.0.1440611.
5
Autoimmunity involving the human sodium/iodide symporter: fact or fiction?
Exp Clin Endocrinol Diabetes. 2001;109(1):35-40. doi: 10.1055/s-2001-11011.
6
[Autoantibody against Na+/I- symporter (NaIS)].[抗钠/碘同向转运体(NaIS)自身抗体]
Nihon Rinsho. 1999 Aug;57(8):1824-8.
7
Autoantibody against thyroid iodide transporter in the sera from patients with Hashimoto's thyroiditis possesses iodide transport inhibitory activity.桥本甲状腺炎患者血清中抗甲状腺碘转运体自身抗体具有碘转运抑制活性。
Biochem Biophys Res Commun. 1996 Nov 1;228(1):199-202. doi: 10.1006/bbrc.1996.1639.
8
The modulation of the human sodium iodide symporter activity by Graves' disease sera.
J Clin Endocrinol Metab. 1998 Apr;83(4):1217-21. doi: 10.1210/jcem.83.4.4701.
9
Implications of the molecular characterization of the sodium-iodide symporter (NIS).钠-碘同向转运体(NIS)分子特征的意义
Exp Clin Endocrinol Diabetes. 1998;106 Suppl 3:S1-10. doi: 10.1055/s-0029-1212036.
10
Absence of interference of serum IgGs from patients with breast cancer and thyroid autoimmunity on the function of human iodide symporter gene stably transfected in CHO cells.乳腺癌和甲状腺自身免疫患者血清IgG对稳定转染于CHO细胞中的人碘转运体基因功能无干扰。
J Endocrinol Invest. 2004 Oct;27(9):862-5. doi: 10.1007/BF03346281.

引用本文的文献

1
Is only Thyroid Peroxidase Antibody Sufficient for Diagnosing Chronic Lymphocytic Thyroiditis?仅甲状腺过氧化物酶抗体就足以诊断慢性淋巴细胞性甲状腺炎吗?
Sisli Etfal Hastan Tip Bul. 2018 Jun 8;52(2):97-102. doi: 10.14744/SEMB.2017.36450. eCollection 2018.
2
Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases.甲状腺自身免疫:抗甲状腺抗体在甲状腺及甲状腺外疾病中的作用
Front Immunol. 2017 May 9;8:521. doi: 10.3389/fimmu.2017.00521. eCollection 2017.
3
The sodium iodide symporter is unlikely to be a thyroid/breast shared antigen.
碘化钠同向转运体不太可能是甲状腺/乳腺共同抗原。
J Endocrinol Invest. 2016 Mar;39(3):323-31. doi: 10.1007/s40618-015-0368-6. Epub 2015 Aug 8.